US men discussing prostate-specific antigen tests with a physician

Annals of Family Medicine

Volumn 4, Issue 5, 2006, Pages 433-436

  McFall, Stephanie L ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Decision making; Health surveys, informed consent; Patient physician communication; Prostate cancer screening; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; DOCTOR PATIENT RELATION; ETHNOLOGY; HUMAN; MALE; PATIENT PARTICIPATION; PROSTATE CANCER; REVIEW; UNITED STATES;

AFRICAN AMERICANS; AGED; COMMUNICATION; HUMANS; INFORMED CONSENT; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; UNITED STATES;

EID: 33749649537     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.576     Document Type: Review

References (21)

1. Briss P, Rimer B, Reilley B, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26:67-80.
2. Becker DM, DeMong LK, Kaplan P, et al. Anticoagulation therapy and primary care internal medicine: a nurse practitioner model for combined clinical science. J Gen Intern Med. 1994;9:525-527.
3. Sheridan SL, Harris RP, Woolf SH. Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med. 2004;26:56-66.
4. Barry MJ. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136:127-135.
5. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Williston Park). 2000;14:267-272, 277-268, 280 passim.
6. Ferrini R, Woolf SH. American College of Preventive Medicine practice policy. Screening for prostate cancer in American men. Am J Prev Med. 1998;15:81-84.
7. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:917-929.
8. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2000;50:34-49.
9. Zoorob R, Anderson R, Cefalu C, Sidani M. Cancer screening guidelines. Am Fam Physician. 2001;63:1101-1112.
10. Braddock CH, 3rd, Fihn SD, Levinson W, Jonsen AR, Pearlman RA. How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting. J Gen Intern Med. 1997;12:339-345.
11. Gotler RS, Flocke SA, Goodwin MA, et al. Facilitating participatory decision-making: what happens in real-world community practice? Med Care. 2000;38:1200-1209.
12. Kaplan SH, Greenfield S, Gandek B, Rogers WH, Ware JE, Jr. Characteristics of physicians with participatory decision-making styles. Ann Intern Med. 1996;124:497-504.
13. Degner LF, Sloan JA. Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol. 1992;45:941-950.
14. Kaplan SH, Gandek B, Greenfield S, Rogers W, Ware JE. Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcomes Study. Med Care. 1995;33:1176-1187.
15. O'Dell KJ, Volk RJ, Cass AR, Spann SJ. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? J Fam Pract. 1999;48:682-688.
16. Chan EC, Vernon SW, O'Donnell FT, et al. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health. 2003;93:779-785.
17. Federman DG, Goyal S, Kamina A, Peduzzi P, Concato J. Informed consent for PSA screening: does it happen? Eff Clin Pract. 1999;2:152-157.
18. National health interview survey, 2000. Machine readable data file and documentation. Hyattsville, Md: National Center for Health Statistics; 2002.
19. Stata Statistical Software [computer program]. Version Release 7.0. College Station, TX: Stata Corporation; 2001.
20. McFall SL. Race/ethnicity and use of prostate specific antigen tests in U.S. men: The University of Texas Health Science Center-Houston School of Public Health; 2005.
21. Dunn AS, Shridharani KV, Lou W, Bernstein J, Horowitz CR. Physician-patient discussions of controversial cancer screening tests. Am J Prev Med. 2001;20:130-134.